DOPEGYT

This brand name is authorized in Estonia, Germany, Hong Kong SAR China, Lithuania, Poland, Romania.

Active ingredients

The drug DOPEGYT contains one active pharmaceutical ingredient (API):

1
UNII 56LH93261Y - METHYLDOPA
 

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
 
Read more about Alphamethyldopa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C02AB Methyldopa C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting
Discover more medicines within C02AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 04630287
EE Ravimiamet 1095331, 1781434
HK Department of Health Drug Office 28038
LT Valstybinė vaistų kontrolės tarnyba 1000656
PL Rejestru Produktów Leczniczych 100020360, 100325549, 100449990, 100454059, 100455650, 100456143, 100456150, 100461571, 100463816, 100467695
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W04208001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈